Daxor Corporation (DXR) vs Stereotaxis Inc. (STXS)

Daxor Corporation and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $105.2M against $59.6M — 1.8× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 4.7×. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −52.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −251.9%) and the lower return on invested capital (−203.6% vs 0.00%). Across the 16 metrics below, Daxor Corporation leads on 10 and Stereotaxis Inc. on 6.

Valuation

Metric DXR STXS Medical Instruments & Supplies median
P/E 4.67 n/m 33.75
P/S n/m 3.36 2.52
P/B 1.48 8.25 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales (14.39) 3.12 2.88
Earnings yield 21.39% (23.76%) (2.67%)
Free cash flow yield (16.76%) (15.34%) 0.09%

Profitability

Metric DXR STXS Medical Instruments & Supplies median
Gross margin 0.00% 55.57% 54.29%
Operating margin 0.00% (75.68%) 1.07%
Net margin (251.91%) (78.45%) (1.61%)
Free cash flow margin 224.51% (51.56%) 1.08%
Return on equity 37.62% (344.36%) (1.32%)
Return on assets 35.90% (48.76%) 0.00%
Return on invested capital 0.00% (203.58%) 0.00%

Growth

Metric DXR STXS Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) (5.46%) 8.85%
EPS growth (last fiscal year) 7.63% 16.67% 8.65%
Revenue growth, 5-year CAGR 0.00% 3.99% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR STXS Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 1.66 1.42 2.48
Net debt to EBITDA 0.00 0.65 0.89

Dividend

Metric DXR STXS Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric DXR STXS Medical Instruments & Supplies median
Market cap 59.57m 105.21m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack